LIPA and metabolic dysfunction-associated steatotic liver disease: Indeed, a significant decrease in lysosomal enzyme activity, particularly lysosomal acid lipase (LAL), is often observed during the progression of MASLD, facilitating the impairment of lysosomal acidification [82,83].